Skip to Content

MYLAN 1730 MYLAN 1730 (Ursodiol 300 mg)

Pill imprint MYLAN 1730 MYLAN 1730 has been identified as Ursodiol 300 mg.

Ursodiol is used in the treatment of biliary cirrhosis; nonalcoholic fatty liver disease; gallbladder disease and belongs to the drug class gallstone solubilizing agents. There is no proven risk in humans during pregnancy. Ursodiol 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ursodiol 300 mg MYLAN 1730 MYLAN 1730
Ursodiol 300 mg MYLAN 1730 MYLAN 1730
Ursodiol 300 mg MYLAN 1730 MYLAN 1730
MYLAN 1730 MYLAN 1730
300 mg
Peach & White
Prescription only
Drug Class:
Gallstone solubilizing agents
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
corn starch
FD&C Yellow No. 6
hydroxypropyl cellulose
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
sodium starch glycolate type A potato
titanium dioxide
ferrosoferric oxide
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
propylene glycol
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0383 UDL Laboratories Inc

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.